116 related articles for article (PubMed ID: 1888817)
1. Nocturnal therapy with famotidine for 1 year is effective in preventing relapse of gastric ulcer.
Berlin RG; Root JK; Cook TJ
Aliment Pharmacol Ther; 1991 Apr; 5(2):161-71. PubMed ID: 1888817
[TBL] [Abstract][Full Text] [Related]
2. Suppression of nocturnal acid secretion with famotidine accelerates gastric ulcer healing.
McCullough AJ; Graham DY; Knuff TE; Lanza FL; Levenson HL; Lyon DT; Munsell WP; Perozza J; Roufail WM; Sinar DR
Gastroenterology; 1989 Oct; 97(4):860-6. PubMed ID: 2570730
[TBL] [Abstract][Full Text] [Related]
3. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs.
Taha AS; Hudson N; Hawkey CJ; Swannell AJ; Trye PN; Cottrell J; Mann SG; Simon TJ; Sturrock RD; Russell RI
N Engl J Med; 1996 May; 334(22):1435-9. PubMed ID: 8618582
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic versus maintenance therapy in the prevention of duodenal ulcer recurrence. Results of a multicentric double-blind randomized trial.
Sobhani I; Chastang C; De Korwin JD; Lamouliatte H; Mégraud F; Guerre J; Elouaer-Blanc L
Gastroenterol Clin Biol; 1995 Mar; 19(3):252-8. PubMed ID: 7781936
[TBL] [Abstract][Full Text] [Related]
5. Maintenance therapy of duodenal ulcer with famotidine. A multicenter United States study.
Texter EC; Navab F; Mantell G; Berman R
Am J Med; 1986 Oct; 81(4B):25-32. PubMed ID: 2877571
[TBL] [Abstract][Full Text] [Related]
6. Double-blind comparison of the safety and efficacy of famotidine with ranitidine in patients with endoscopically diagnosed peptic ulcer.
Sawant PD; Nanivadekar SA; Patel HD; Shroff CP; Oke VG; Jha RJ; Bowalekar SK; Navani SR; Raghu CN
J Assoc Physicians India; 1990 Sep; 38 Suppl 1():723-6. PubMed ID: 2092029
[TBL] [Abstract][Full Text] [Related]
7. Famotidine once-a-day in the therapy of acute, benign gastric ulcer: a worldwide experience.
Simon B; Müller P; Dammann HG
J Clin Gastroenterol; 1987; 9 Suppl 2():19-22. PubMed ID: 2887614
[TBL] [Abstract][Full Text] [Related]
8. Gastroprotective efficacy and safety of single-tablet ibuprofen/famotidine vs ibuprofen in older persons.
Bello AE; Kent JD; Holt RJ
Phys Sportsmed; 2015 Jul; 43(3):193-9. PubMed ID: 26165391
[TBL] [Abstract][Full Text] [Related]
9. Effect of FRG-8813, a new-type histamine H(2)-receptor antagonist, on the recurrence of gastric ulcer after healing by drug treatment in rats.
Ajioka H; Miyake H; Matsuura N
Pharmacology; 2000 Aug; 61(2):83-90. PubMed ID: 10940781
[TBL] [Abstract][Full Text] [Related]
10. Double-blind randomized trials of single-tablet ibuprofen/high-dose famotidine vs. ibuprofen alone for reduction of gastric and duodenal ulcers.
Laine L; Kivitz AJ; Bello AE; Grahn AY; Schiff MH; Taha AS
Am J Gastroenterol; 2012 Mar; 107(3):379-86. PubMed ID: 22186979
[TBL] [Abstract][Full Text] [Related]
11. Famotidine: nocturnal administration for gastric ulcer healing. Results of multicenter trials in Austria and Germany.
Dammann HG; Walter TA; Hentschel E; Müller P; Simon B
Digestion; 1985; 32 Suppl 1():45-50. PubMed ID: 3905468
[TBL] [Abstract][Full Text] [Related]
12. Famotidine: proven once-a-day treatment for gastric ulcer.
Dammann HG; Walter TA; Hentschel E; Muller P; Simon B
Scand J Gastroenterol Suppl; 1987; 134():29-33. PubMed ID: 3310200
[TBL] [Abstract][Full Text] [Related]
13. Lansoprazole versus famotidine: efficacy and tolerance in the acute management of duodenal ulceration.
Hotz J; Kleinert R; Grymbowski T; Hennig U; Schwarz JA
Aliment Pharmacol Ther; 1992 Feb; 6(1):87-95. PubMed ID: 1543819
[TBL] [Abstract][Full Text] [Related]
14. Comparison between single morning and bedtime doses of 40 mg famotidine for the treatment of duodenal ulcer.
Marenco G; Menardo G; Pallini P; Rossini FP; Saggioro A
Aliment Pharmacol Ther; 1989 Jun; 3(3):285-91. PubMed ID: 2520624
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the efficacy of irsogladine maleate and famotidine for the healing of gastric ulcers after Helicobacter pylori eradication therapy: a randomized, controlled, prospective study.
Murakami K; Okimoto T; Kodama M; Tanahashi J; Mizukami K; Shuto M; Abe H; Arita T; Fujioka T
Scand J Gastroenterol; 2011 Mar; 46(3):287-92. PubMed ID: 21073372
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 40 mg famotidine nightly and 150 mg ranitidine b.d.: ulcer healing and symptom relief in benign gastric ulcer.
Cochran KM; Cockel R; Crowe J; Dickinson RJ; Gent AE; Kennedy NP; Royston CM; Cedar E; Mann SG
Aliment Pharmacol Ther; 1989 Oct; 3(5):461-70. PubMed ID: 2518859
[TBL] [Abstract][Full Text] [Related]
17. [Therapy of peptic ulcers with famotidine. Report of experiences with an open clinical study].
Dragosics B; Weiss W; Okulski G
Wien Med Wochenschr; 1992; 142(18):408-13. PubMed ID: 1475986
[TBL] [Abstract][Full Text] [Related]
18. Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial.
Taha AS; McCloskey C; Prasad R; Bezlyak V
Lancet; 2009 Jul; 374(9684):119-25. PubMed ID: 19577798
[TBL] [Abstract][Full Text] [Related]
19. Risk of upper gastrointestinal ulcers in patients with osteoarthritis receiving single-tablet ibuprofen/famotidine versus ibuprofen alone: pooled efficacy and safety analyses of two randomized, double-blind, comparison trials.
Bello AE; Kent JD; Grahn AY; Rice P; Holt RJ
Postgrad Med; 2014 Jul; 126(4):82-91. PubMed ID: 25141246
[TBL] [Abstract][Full Text] [Related]
20. Lafutidine can improve the quality of gastric ulcer healing in humans: a randomized, controlled, multicenter trial.
Higuchi K; Watanabe T; Tominaga K; Shiba M; Nakagawa K; Uno H; Kitada K; Satoh H; Chono S; Oshitani N; Fujiwara Y; Arakawa T
Inflammopharmacology; 2006 Dec; 14(5-6):226-30. PubMed ID: 17186182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
